Sofosbuvir and Ribavirin to Treat Hepatitis C Virus Genotype 4 Infection in a 65-Year-Old Patient With Diabetes and Low Platelet: A Case Report
| Author | Nawfal R Hussein | en |
| Orcid | Nawfal R Hussein [0000-0002-7813-9198] | en |
| Issued Date | 2016-10-01 | en |
| Abstract | Introduction: Hepatitis C virus (HCV) is a major public health problem especially in the elderly. The classical interferon/ribavirin regimen was unfavorable for elderly patents due to intolerability and adverse effects. More studies are needed about the safety profile of new direct-acting antiviral (DAA) in the elderly. Case Presentation: Here, a case of chronic HCV was described in a 65-year-old female with diabetes and low platelet count. The patient was treated successfully by a combination of sofosbuvir+ ribavirin without major side effects. Conclusions: This report highlighted the importance and the safety of this regimen to treat HCV in the elderly. | en |
| DOI | https://doi.org/10.17795/iji-36642 | en |
| Keyword | Hepatitis C Virus | en |
| Keyword | Direct-Acting Antiviral | en |
| Keyword | Iraq | en |
| Keyword | Elderly | en |
| Publisher | Brieflands | en |
| Title | Sofosbuvir and Ribavirin to Treat Hepatitis C Virus Genotype 4 Infection in a 65-Year-Old Patient With Diabetes and Low Platelet: A Case Report | en |
| Type | Case Report | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 14761-pdf.pdf
- Size:
- 90.78 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF